DOPING CONTROL OFFICER AGREEMENT
Helpful Links for Education, Drug Look-up, Products, Prohibited list, etc
- Drug/Prescription Lookup Tool (GlobalDro.com – Select Weightlifting as the sport)
- Report Doping
- ADeL– WADA’s educational online tool for Athletes, Coaches, and Parents
- ADeL – Submit your certificate once you complete your ADeL training.
- Informed Choice
- Informed-Sport
- NSF Certified Products for Sport®
- United States Anti-Doping Agency
- WADA
The following ALF form is for providing detailed contact information of all USA Powerlifting athletes who are notified you are in the Registered Testing Pool to help the administration with performing Out-of-Meet tests. The form is to be filled out online by the stated deadline each quarter and is automatically submitted to the Anti-Doping Chair responsible for OMTs. Failure to submit your ALF by the deadline, or to keep your whereabouts accurate will result in removal from teams and suspension.
USA Powerlifting Anti-Doping Rules
Athlete Retirement Form
Note from the USA Powerlifting TUE Chair Dr. Kris Hunt (12/2016):
With the recent doping failures, the TUE committee will be making more regular announcements regarding Therapeutic Use Exemptions (TUE).
Any medication that you are on should be cross-checked (by YOU) on the database: GlobalDro.com
If you have a medication that is prescribed that appears on this list, you need to file for a TUE.
TUE’s need to be received NO LATER than 6 weeks prior to your intended competition. It is YOUR RESPONSIBILITY and YOURS ALONE to ensure the proper paperwork is submitted on time.
A couple of items worth mentioning:
1. Testosterone or any derivatives thereof will not be approved by historical precedent in our organization.
2. We are having mountains of TUE requests for Adderall or similar stimulants for ADHD. For those of you that are not aware, many medications used for the treatment of ADHD are amphetamines. If abused, they can enhance performance. We are not going to question your diagnosis of ADHD; however, we are now asking for more substantive information regarding your diagnosis. A letter from your doctor stating, “she/he has a hard time concentrating at work/school” will not suffice. We are now requiring formal ADHD testing via a primary care provider or psychiatrist. This is to ensure the integrity of the sport, as Adderall is now being abused in epidemic proportions, with and without a physician’s prescription.
Within the 2008 Calendar year, the USA Powerlifting conducted a total of 798 drug tests with the following breakdown:
- Total tests done by Quest Diagnostics: 769
- Total Tests done by UCLA, Cologne Labs: 29
- Positive tests: 13
- In Competition Tests: 700
- Out of Meet Tests: 98
Within the 2005 Calendar year, the USA Powerlifting conducted a total of 716 drug tests with the following breakdown:
- Quest Lab tests: 648, 21 positives
- UCLA Lab tests: 68, 3 positives
- Total In Meet Tests (IMT): 716
- Total Out of Meet Tests (OMT): 36
Within the 2004 Calendar year, the USA Powerlifting conducted a total of 827 drug tests with the following breakdown:
- Quest Lab tests: 781, 27 positives
- UCLA Lab tests: 46, 2 positives
- Total In Meet Tests (IMT): 701
- Total Out of Meet Tests (OMT): 126
Larry Maile, USA Powerlifting President
- Therapeutic Use Exemptions Committee Page
- Current List of USA Powerlifting’s Suspended Members
- List of Athletes Eligible for Reinstatement
- WADA & USADA Prohibited Substances List
- Notice: Replacement Therapy (2/18/2000)
- Letter from USA Powerlifting President Michael Overdeer regarding USA Powerlifting Drug Testing Programs
- Message from the USA Powerlifting Drug Testing Chairman (archive letter)
- Doping Control Program Overview
- Letter from USA Powerlifting Drug Testing Laboratory (Verifying number of steroid tests – 1997)
- Doping Control Report (statistics 7/96-6/97)
- Quest Diagnostics Letter: Number of 1998 and 1999 Drug Tests (4/16/2000)
- Beware of the Super “Natural” Supplement – (7/5/2000)
- Drug Testing Committee Report to the USA Powerlifting National Governing Body Meeting – (7/12/2001)